You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
天士力(600535.SH):天士力產業集團對數智中醫藥科技公司進行增資
格隆匯 02-24 18:30

格隆匯2月24日丨天士力(600535.SH)公佈,根據天士力產業集團和華潤三九醫藥股份有限公司關於公司控制權轉讓事項的戰略合作相關安排,天士力醫藥集團股份公司結合自身業務發展策略,擬同意天士力產業集團對數智中醫藥科技公司進行增資。本次增資完成後,標的公司的註冊資本變由2,000萬元增加至6,666.67萬元,天士力產業集團和本公司分別持有標的公司70%和30%的股權,標的公司由本公司全資子公司變為參股子公司,並將不再納入本公司合併報表範圍。通過此次合作,上市公司將更加聚焦現有相關的業務發展,同時兼顧早期前端科學技術的研究開發需要,藉助關聯方在產業、專家等相關資源優勢,繼續探索數智中醫藥科學技術的研究發展。

本次關聯方對數智中醫藥科技公司的增資擴股,是基於公司控制權轉讓事項的總體戰略安排與後續合作的考慮,一方面,本次合作有利於公司進一步聚焦上市公司主業,提高核心競爭力,提升發展質量和效率;另一方面,通過增資為數智中醫藥科技公司注入更多科研資金,同時藉助生物醫藥產業集團公司在專家、產業、市場等方面的優勢和影響力推動其自身業務的發展和經營業績的提升,更好地探索數智中醫藥早期技術發展,未來為更多中醫藥企業的生產與研發、醫療機構的診療智能化、以及科研院所的科研教學活動等商業端提供數據化支持服務。

本次交易完成後,數智中醫藥科技公司不再納入合併報表範圍,不會對公司正常的生產經營活動產生重大不利影響。本次關聯交易事項符合公司長遠利益,不會損害公司股東特別是中小股東的利益。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account